Ignite Creation Date:
2024-05-06 @ 1:11 AM
Last Modification Date:
2024-10-26 @ 11:00 AM
Study NCT ID:
NCT01755078
Status:
COMPLETED
Last Update Posted:
2014-08-05
First Post:
2012-12-19
Brief Title:
Long Term Evaluation of Sevelamer HCl vs Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients
Sponsor:
Chugai Pharma Taiwan
Organization:
Chugai Pharma Taiwan
Study Overview
Official Title:
Long Term Evaluation of Sevelamer HCl vs Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients
Status:
COMPLETED
Status Verified Date:
2012-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study is designed to compare sevelamer vs calcium-based phosphate binder in hemodialysis patients to achieve full-scale of medical care including reduction of atherosclerotic risk factors reduction of vascular access reconstruction rate and pharmacoeconomic analysis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None